Rhaeos
Pre-clinicalNon-invasive. Wireless. Wearable. FlowSense® assesses hydrocephalus shunt flow in minutes. Shunt malfunction in hydrocephalus patients is challenging to detect with current methods. Patients 1 Million Americans live with hydrocephalus Emergency Department Discharge Rate 70% Pediatric patients discharged after visiting the ED for symptoms of shunt malfunction Readmission Rate 16% Patients readmitted within 30 days after […]
About
Non-invasive. Wireless. Wearable. FlowSense® assesses hydrocephalus shunt flow in minutes. Shunt malfunction in hydrocephalus patients is challenging to detect with current methods. Patients 1 Million Americans live with hydrocephalus Emergency Department Discharge Rate 70% Pediatric patients discharged after visiting the ED for symptoms of shunt malfunction Readmission Rate 16% Patients readmitted within 30 days after […]
Funding History
2Total raised: $17.5M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile